Glucaric acid

Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glucaric acid?

Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glucaric acid

MeSH term MeSH ID Detail
Rickets, Hypophosphatemic D063730 1 associated lipids
Carcinogenesis D063646 3 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Atherosclerosis D050197 85 associated lipids
Micronuclei, Chromosome-Defective D048629 33 associated lipids
Neurocysticercosis D020019 1 associated lipids
Iron Overload D019190 11 associated lipids
Postoperative Hemorrhage D019106 7 associated lipids
Anemia, Iron-Deficiency D018798 6 associated lipids
Myocardial Stunning D017682 10 associated lipids
Myocardial Ischemia D017202 11 associated lipids
Critical Illness D016638 13 associated lipids
Blood Loss, Surgical D016063 6 associated lipids
Myocardial Reperfusion Injury D015428 20 associated lipids
von Willebrand Diseases D014842 2 associated lipids
Vitamin D Deficiency D014808 13 associated lipids
Tuberculosis, Pulmonary D014397 18 associated lipids
Thrombophlebitis D013924 6 associated lipids
Per page 10 20 50 100 | Total 85

PubChem Associated disorders and diseases

What pathways are associated with Glucaric acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glucaric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glucaric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glucaric acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with Glucaric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glucaric acid?

Knock-out

Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Glucaric acid

Download all related citations
Per page 10 20 50 100 | Total 1061
Authors Title Published Journal PubMed Link
Hedenus M and Birgegård G The role of iron supplementation during epoietin treatment for cancer-related anemia. 2009 Med. Oncol. pmid:18473194
Ginsberg G and Rice DC Does rapid metabolism ensure negligible risk from bisphenol A? 2009 Environ. Health Perspect. pmid:20049111
Fior S and Gerola PD Impact of ubiquitous inhibitors on the GUS gene reporter system: evidence from the model plants Arabidopsis, tobacco and rice and correction methods for quantitative assays of transgenic and endogenous GUS. 2009 Plant Methods pmid:20042078
Luo Z et al. Resistin induces insulin resistance by both AMPK-dependent and AMPK-independent mechanisms in HepG2 cells. 2009 Endocrine pmid:19440859
Rodionov DA et al. Genomic encyclopedia of sugar utilization pathways in the Shewanella genus. 2010 BMC Genomics pmid:20836887
Chaudhuri RR et al. Complete genome sequence and comparative metabolic profiling of the prototypical enteroaggregative Escherichia coli strain 042. 2010 PLoS ONE pmid:20098708
Laidlaw M et al. Effects of a breast-health herbal formula supplement on estrogen metabolism in pre- and post-menopausal women not taking hormonal contraceptives or supplements: a randomized controlled trial. 2010 Breast Cancer (Auckl) pmid:21234288
Lippow SM et al. Engineering enzyme specificity using computational design of a defined-sequence library. 2010 Chem. Biol. pmid:21168766
Suzuki E et al. Identification of valproic acid glucuronide hydrolase as a key enzyme for the interaction of valproic acid with carbapenem antibiotics. 2010 Drug Metab. Dispos. pmid:20551238
Hoffman K et al. Exposure to polyfluoroalkyl chemicals and attention deficit/hyperactivity disorder in U.S. children 12-15 years of age. 2010 Environ. Health Perspect. pmid:20551004
Sienkiewicz-Porzucek A et al. Mild reductions in mitochondrial NAD-dependent isocitrate dehydrogenase activity result in altered nitrate assimilation and pigmentation but do not impact growth. 2010 Mol Plant pmid:20035036
Sturm B et al. In vitro study on the effects of iron sucrose, ferric gluconate and iron dextran on redox-active iron and oxidative stress. 2010 Arzneimittelforschung pmid:20712137
Swarnalatha G et al. Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress. 2010 Saudi J Kidney Dis Transpl pmid:20814119
Bager P and Dahlerup JF The health care cost of intravenous iron treatment in IBD patients depends on the economic evaluation perspective. 2010 J Crohns Colitis pmid:21122539
Froessler B and Papendorf D Intravenous iron sucrose--an effective and attractive modality for perioperative anaemia management. 2010 Anaesth Intensive Care pmid:20865896
Saluk-Juszczak J A comparative study of antioxidative activity of calcium-D-glucarate, sodium-D-gluconate and D-glucono-1,4-lactone in a human blood platelet model. 2010 Platelets pmid:20873960
Yoon J et al. Postoperative high-dose intravenous iron sucrose with low dose erythropoietin therapy after total hip replacement. 2010 Korean J. Intern. Med. pmid:21179286
Dangsuwan P and Manchana T Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy. 2010 Gynecol. Oncol. pmid:20051288
Lajolo C et al. Calcium glucarate inhibits DMBA-induced oral carcinogenesis in the hamster: histomorphometric evaluation. 2010 Anticancer Res. pmid:20393005
Wu CJ et al. Comparison of parenteral iron sucrose and ferric chloride during erythropoietin therapy of haemodialysis patients. 2010 Nephrology (Carlton) pmid:20377770
McMahon LP et al. Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial. 2010 Nephrol. Dial. Transplant. pmid:19906658
Stancu S et al. Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease? 2010 Clin J Am Soc Nephrol pmid:20019121
Rombouts K and Marra F Molecular mechanisms of hepatic fibrosis in non-alcoholic steatohepatitis. 2010 Dig Dis pmid:20460917
Rangel EB et al. Labile plasma iron generation after intravenous iron is time-dependent and transitory in patients undergoing chronic hemodialysis. 2010 Ther Apher Dial pmid:20438541
Tampi R Delayed adverse reactions to iron polymaltose and iron sucrose. 2010 Intern Med J pmid:20446963
Garcia-Fernandez N et al. Randomized clinical trial on acute effects of i.v. iron sucrose during haemodialysis. 2010 Nephrology (Carlton) pmid:20470276
Firoz BF et al. Eosinophilic fasciitis secondary to intravenous iron infusions. 2010 Dermatol. Online J. pmid:20492822
Gupta A et al. Response to iron sucrose in dialysis patients sensitive to iron dextran. 2010 Saudi J Kidney Dis Transpl pmid:20587886
Zhang ZW et al. The plastid hexokinase pHXK: a node of convergence for sugar and plastid signals in Arabidopsis. 2010 FEBS Lett. pmid:20650273
Okada DR et al. 99mTc-glucarate kinetics differentiate normal, stunned, hibernating, and nonviable myocardium in a perfused rat heart model. 2010 Eur. J. Nucl. Med. Mol. Imaging pmid:20652807
Kell DB Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples. 2010 Arch. Toxicol. pmid:20967426
Chinnappa S and Bhandari S Influence of intravenous iron therapy on novel markers of iron deficiency. 2010 Int J Artif Organs pmid:20593351
Birgegård G et al. High incidence of iron depletion and restless leg syndrome (RLS) in regular blood donors: intravenous iron sucrose substitution more effective than oral iron. 2010 Vox Sang. pmid:20598107
Johnson AC et al. Parenteral iron formulations differentially affect MCP-1, HO-1, and NGAL gene expression and renal responses to injury. 2010 Am. J. Physiol. Renal Physiol. pmid:20504881
Fernández-Gallego J et al. [Treatment with intravenous iron and ferritin level]. 2010 Nefrologia pmid:20514109
Moon TS et al. Use of modular, synthetic scaffolds for improved production of glucaric acid in engineered E. coli. 2010 Metab. Eng. pmid:20117231
Li LO et al. Early hepatic insulin resistance in mice: a metabolomics analysis. 2010 Mol. Endocrinol. pmid:20150186
Do PT et al. The influence of fruit load on the tomato pericarp metabolome in a Solanum chmielewskii introgression line population. 2010 Plant Physiol. pmid:20841452
Simpson JA et al. Letter 2: Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery (Br J Surg 2009; 96: 1122-1128). 2010 Br J Surg pmid:20069594
Ranganathan P and Pramesh CS Letter 1: Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery (Br J Surg 2009; 96: 1122-1128). 2010 Br J Surg pmid:20069595
Kowalczyk MC et al. Synergistic effects of combined phytochemicals and skin cancer prevention in SENCAR mice. 2010 Cancer Prev Res (Phila) pmid:20103723
Hu Q et al. Homozygous deletion of CDKN2A/2B is a hallmark of iron-induced high-grade rat mesothelioma. 2010 Lab. Invest. pmid:20065947
Yang Z et al. Symbiosis between microorganisms from kombucha and kefir: Potential significance to the enhancement of kombucha function. 2010 Appl. Biochem. Biotechnol. pmid:18810658
Agarwal R et al. Proteinuria induced by parenteral iron in chronic kidney disease--a comparative randomized controlled trial. 2011 Clin J Am Soc Nephrol pmid:20876669
Auerbach M Should intravenous iron be upfront therapy for iron deficiency anemia? 2011 Pediatr Blood Cancer pmid:21298731
Crary SE et al. Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy. 2011 Pediatr Blood Cancer pmid:21298748
Ibert M et al. Evidence of benzilic rearrangement during the electrochemical oxidation of D-glucose to D-glucaric acid. 2011 Carbohydr. Res. pmid:21269605
Vanderford NL The role of MafA in regulating cytokine expression in pancreatic beta cells. 2011 J. Biol. Chem. pmid:21239506
Fenwick S and Peebles G Total dose infusion of intravenous iron in patients with chronic kidney disease receiving haemodialysis. 2011 J Ren Care pmid:21288317
Malovrh M et al. The influence of need-based, continuous, low-dose iron replacement on hemoglobin levels in hemodialysis patients treated with erythropoiesis-stimulating agents. 2011 Artif Organs pmid:20618233